Nurix Therapeutics, Inc.NRIXNASDAQ
Loading
Year-over-year book value per share growth
Latest
28.09%
↑ 4876% vs avg
Percentile
P81
Within normal range
Streak
1 qtr
Consecutive growthAccelerating
Average
0.56%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 28.09% |
| Q3 2025 | -17.11% |
| Q2 2025 | -7.28% |
| Q1 2025 | -14.37% |
| Q4 2024 | 29.80% |
| Q3 2024 | -12.87% |
| Q2 2024 | 93.35% |
| Q1 2024 | -16.19% |
| Q4 2023 | -14.69% |
| Q3 2023 | -10.26% |
| Q2 2023 | -5.56% |
| Q1 2023 | -9.90% |
| Q4 2022 | -16.40% |
| Q3 2022 | 13.35% |
| Q2 2022 | -13.20% |
| Q1 2022 | -10.91% |
| Q4 2021 | -9.14% |
| Q3 2021 | -6.98% |
| Q2 2021 | 30.49% |
| Q1 2021 | -7.12% |
| Q4 2020 | -58.70% |
| Q3 2020 | 493.63% |
| Q2 2020 | 191.07% |
| Q1 2020 | -633.29% |
| Q4 2019 | 0.00% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |